resiquimod has been researched along with Herpes Simplex in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kinghorn, GR; Magaret, A; Mark, KE; Meng, TC; Sacks, SL; Selke, S; Slade, HB; Spruance, S; Wald, A | 1 |
Martinez-Martin, N; Viejo-Borbolla, A | 1 |
Jones, T | 1 |
Hengge, UR; Meykadeh, N | 1 |
Beaurline, JM; Gerster, JF; Gibson, SJ; Imbertson, LM; Miller, RL; Myhre, PE; Reiter, MJ; Tamulinas, CB; Tomai, MA; Wagner, TL | 1 |
2 review(s) available for resiquimod and Herpes Simplex
Article | Year |
---|---|
Toll-like receptor-mediated recognition of herpes simplex virus.
Topics: Aminoquinolines; Animals; Cytokines; Herpes Simplex; Humans; Imidazoles; Imiquimod; Mice; Signal Transduction; Simplexvirus; Toll-Like Receptors | 2010 |
Resiquimod 3M.
Topics: Administration, Topical; Antiviral Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contraindications; Eczema; Herpes Simplex; Humans; Imidazoles; Papillomavirus Infections; Structure-Activity Relationship | 2003 |
1 trial(s) available for resiquimod and Herpes Simplex
Article | Year |
---|---|
Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrences.
Topics: Acyclovir; Adolescent; Adult; Aged; Cytokines; Double-Blind Method; Female; Gels; Herpes Simplex; Humans; Imidazoles; Male; Middle Aged; Recurrence; Simplexvirus; Valacyclovir; Valine; Wound Healing; Young Adult | 2014 |
2 other study(ies) available for resiquimod and Herpes Simplex
Article | Year |
---|---|
[Topical immunomodulators in dermatology].
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts | 2003 |
Immunomodulating and antiviral activities of the imidazoquinoline S-28463.
Topics: 2',5'-Oligoadenylate Synthetase; Adjuvants, Immunologic; Aminoquinolines; Animals; Antiviral Agents; Cytokines; Female; Guinea Pigs; Herpes Simplex; Herpesvirus 1, Human; Interferon Inducers; Interferon-alpha; Macaca fascicularis; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred Strains; Tumor Necrosis Factor-alpha | 1995 |